FARMACOSMO S.P.A. PRESS RELEASES
THE BOARD OF DIRECTORS APPROVES THE
CORPORATE EVENTS CALENDAR 2023
Napoles, January 23rd, 2023
Farmacosmo S.p.A. ("Company", "Farmacosmo"), a company active in the Health, Pharma & Beauty sector, listed on the Euronext Growth Milan market of Borsa Italiana, announces that on today's day the Board of Directors has approved the Corporate Events Calendar 2023, pursuant to Article 17 of the Euronext Growth Milan Issuers' Regulation.
Board of Directors | |
February 13th, 2023 | Review of economic and financial management data relating to Revenues and main KPIs for |
the fourth quarter of 2022 (unaudited) | |
March 29th, 2023 | Board of Directors |
Approval of the draft Financial Statements and the Consolidated Balance Sheet as at | |
December 31st, 2022 | |
Board of Directors | |
Aprile 24th, 2023 | Review of the economic and financial management data relating to Revenues and main KPIs |
for the first quarter of 2023 (unaudited) | |
Shareholders' Meeting | |
April 28th, 2023 | Approval of the Financial Statements as at December 31st, 2022, and presentation of the |
Consolidated Balance Sheet as at December 31st, 2022 | |
Board of Directors | |
July 24th, 2023 | Review of the economic and financial management data relating to Revenues and main KPIs |
for the second quarter of 2023 (unaudited) | |
Board of Directors | |
September 28th, | Approval of the Interim Financial Report as at June 30th, 2023 (voluntarily subjected to a |
2023 | |
limited audit) | |
Board of Directors | |
October 26th, 2023 | Review of the economic and financial management data relating to Revenues and main KPIs |
for the third quarter of 2023 (unaudited) | |
Any changes to the calendar will be promptly communicated to the market.
The Corporate Events Calendar is available on the www.farmacosmoinvestors.comwebsite, 'Investors/Corporate Events' section.
***
This press release is available on the www.farmacosmoinvestors.com website,"Investors/Press Releases" section and on the authorized storage mechanism "eMarket Storage" (www.emarketstorage.com).
***
PRESS RELEASES
THE SOCIETY
Farmacosmo is a company active in the Health, Pharma & Beauty sectors. The company's business model is based on the circular model of the l(ea)n strategy, and is divided into three main business areas: Logistics, Intelligence and Node. Logistics: enables the management and fulfilment of up to 12,000 orders per day, with delivery times of up to 20 hours from carrier picking and just-intime procurement ('zero warehouse' policy). Intelligence: includes strategy definition, competitive positioning and customer journey activities, which enabled the company to intercept c. 188,000 customers in 2021. Recurring customers contributed 74% of the annual retail stream turnover. The average cart value of active customers in the retail stream amounted to €92 (€109 related to recurring customers). Node: R&D activities, process innovation and IT infrastructure of the company. Over the past five years, Farmacosmo's sales value has grown by 54% (CAGR 2016-2021) and will be around €58 million in 2021. The Farmacosmo ecosystem aims to pursue standards of excellence in every part of its value chain, being inspired by compliance with ESG principles at all stages of the logistics process (from the packaging used for online orders to carbon compensation initiatives) and in the valorisation of its employees, the company's strategic asset. Farmacosmo's commitment to ESG is also underlined by the publication of its Sustainability Report 2021.
IDENTIFICATION CODES
Ordinary Shares: ISIN IT0005487670 (Ticker COSMO)
Warrant Farmacosmo 2022-2025: ISIN IT0005487415 (Ticker WCOSMO)
FOR FURTHER INFORMATION: | ||
INVESTOR RELATIONS MANAGER | EURONEXT GROWTH ADVISOR | INVESTOR & MEDIA RELATIONS ADVISOR |
Farmacosmo | Illimity Bank | IR Top Consulting |
Via Crispi, 51 - 80121 Napoli | Via Soperga, 9 - 20124 Milano | Via Bigli, 19 - 20121 Milano |
Tel. +39 02 50042143 | Tel. +39 02 82849699 | Tel. +39 02 45473883 |
Paolo Cimmino ir@farmacosmo.it | farmacosmo@illimity.com | Pietro Autelitano ir@irtop.com |
Domenico Gentileufficiostampa@irtop.com |
Attachments
- Original Link
- Original Document
- Permalink
Disclaimer
Farmacosmo S.p.A. published this content on 23 January 2023 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 01 February 2023 16:47:06 UTC.
